Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

Sanofi reception

Sanofi/Regeneron start first filings for PD-1 drug cemiplimab

The pharma partners begin with a skin cancer filing to the US FDA

- PMLiVE

Agios appoints Celgene’s Jackie Fouse

She joins the pharma group’s board of directors

Conversis appoints new vendor manager

Gina Gulotta joins the translation provider from RWS

Brexit talks threaten supply of medical technologies

As concern grows that the outcome could undermine the regulatory framework

- PMLiVE

Vivid MedComms bolster their business with a new senior appointment

A new hire for Vivid MedComms, part of the Lucid Group of companies

Lucid Group Communications Limited

Evolve and thrive vs wait and wither

What is the future of your marketing function?

Sanofi reception

After some big setbacks, Sanofi talks up its R&D portfolio

Hopes its pipeline of 71 projects delivers strong sales

- PMLiVE

Gilead adds to CAR-T assets with Cell Design Labs buyout

Gains full control of the biotherapeutics firm following its acquisition of Kite Pharma

- PMLiVE

GSK gets another approval for Nucala in US

Its antibody is first approved treatment for a rare and sometimes life-threatening vascular disease

- PMLiVE

New NHS Alliance launches healthcare TV programme

In Search of Wellness follows those on a quest to improve healthcare

- PMLiVE

Millennials’ disappointing medicine habits

Survey finds only 60% of 18-34 years olds take treatments as prescribed

Andy Busch joins Shire as its CSO and head of research and development

And Howard Mayer is promoted to chief medical officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links